-
1
-
-
0029875388
-
Pulmonary hypertension in chronic liver disease
-
Mandell MS, Groves BM. Pulmonary hypertension in chronic liver disease. Clin Chest Med 1996;17:17-33.
-
(1996)
Clin Chest Med
, vol.17
, pp. 17-33
-
-
Mandell, M.S.1
Groves, B.M.2
-
2
-
-
0037332028
-
Portopulmonary hypertension: A tale of two circulations
-
Budhiraja R, Hassoun PM. Portopulmonary hypertension: a tale of two circulations. Chest 2003;123:562-576
-
(2003)
Chest
, vol.123
, pp. 562-576
-
-
Budhiraja, R.1
Hassoun, P.M.2
-
3
-
-
0030317077
-
Frequency and clinical implications of mincreased pulmonary artery pressures in liver transplant patients
-
Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, et al. Frequency and clinical implications of mincreased pulmonary artery pressures in liver transplant patients. Mayo Clinic Proc 1996;71:543-551
-
(1996)
Mayo Clinic Proc
, vol.71
, pp. 543-551
-
-
Castro, M.1
Krowka, M.J.2
Schroeder, D.R.3
Beck, K.C.4
Plevak, D.J.5
Rettke, S.R.6
-
4
-
-
0025977116
-
Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splachnic hemodynamics
-
Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splachnic hemodynamics. Gastroenterology 1991;100:520-528
-
(1991)
Gastroenterology
, vol.100
, pp. 520-528
-
-
Hadengue, A.1
Benhayoun, M.K.2
Lebrec, D.3
Benhamou, J.P.4
-
5
-
-
33646269035
-
Pulmonary arterial hypertension in France: Results from a national registry
-
Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, et al. Pulmonary arterial hypertension in France: results from a national registry. Am Rev Respir Crit Care Med 2006;173:1023-1030
-
(2006)
Am Rev Respir Crit Care Med
, vol.173
, pp. 1023-1030
-
-
Humbert, M.1
Sitbon, O.2
Chaouat, A.3
Bertocchi, M.4
Habib, G.5
Gressin, V.6
-
7
-
-
47149115276
-
Clinical risk factors for portopulmonary hypertension
-
Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, et al. Clinical risk factors for portopulmonary hypertension. Hepatology 2008;48:196-203.
-
(2008)
Hepatology
, vol.48
, pp. 196-203
-
-
Kawut, S.M.1
Krowka, M.J.2
Trotter, J.F.3
Roberts, K.E.4
Benza, R.L.5
Badesch, D.B.6
-
8
-
-
65549105008
-
Genetic risk fact for portopulmonary hypertension in patients with advanced liver disease
-
Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, et al. Genetic risk fact for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med 2009;179:835-842
-
(2009)
Am J Respir Crit Care Med
, vol.179
, pp. 835-842
-
-
Roberts, K.E.1
Fallon, M.B.2
Krowka, M.J.3
Brown, R.S.4
Trotter, J.F.5
Peter, I.6
-
9
-
-
53749103602
-
Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups
-
Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transpl 2008;8:1-9.
-
(2008)
Am J Transpl
, vol.8
, pp. 1-9
-
-
Swanson, K.L.1
Wiesner, R.H.2
Nyberg, S.L.3
Rosen, C.B.4
Krowka, M.J.5
-
10
-
-
0025977116
-
Pulmonary hypertension complicating portal hypertension: Prevalence and relation to splachnic hemodynamics
-
Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splachnic hemodynamics. Gastroenterology 1991;100:520-528
-
(1991)
Gastroenterology
, vol.100
, pp. 520-528
-
-
Hadengue, A.1
Benhayoun, M.K.2
Lebrec, D.3
Benhamou, J.P.4
-
11
-
-
0032578279
-
Primary pulmonary hypertension
-
Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet1998;352:719- 725
-
(1998)
Lancet
, vol.352
, pp. 719-725
-
-
Gaine, S.P.1
Rubin, L.J.2
-
12
-
-
7244243724
-
Cytokines in portopulmonary hypertension
-
Pellicelli AM. Cytokines in portopulmonary hypertension. Gut 2004;53:1721.
-
(2004)
Gut
, vol.53
, pp. 1721
-
-
Pellicelli, A.M.1
-
13
-
-
0023473478
-
Coexistent pulmonary and portal hypertension: Morphologic and clinical features
-
Edwards BS, Weir EK, Edwards WD, Ludwig J, Dykoski RK, Edwards JE. Coexistent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 1987;10:1233-1238
-
(1987)
J Am Coll Cardiol
, vol.10
, pp. 1233-1238
-
-
Edwards, B.S.1
Weir, E.K.2
Edwards, W.D.3
Ludwig, J.4
Dykoski, R.K.5
Edwards, J.E.6
-
14
-
-
0029166752
-
Different distribution of plexiform lesions in primary and secondary pulmonary hypertension
-
Jamison BM, Michel RP. Different distribution of plexiform lesions in primary and secondary pulmonary hypertension. Hum Pathol 1995;26:987-993
-
(1995)
Hum Pathol
, vol.26
, pp. 987-993
-
-
Jamison, B.M.1
Michel, R.P.2
-
16
-
-
2342453333
-
Portopulmonary hy- pertension and hepatopulmonary syndrome
-
Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hy- pertension and hepatopulmonary syndrome. Lancet 2004;363:1461-1468
-
(2004)
Lancet
, vol.363
, pp. 1461-1468
-
-
Hoeper, M.M.1
Krowka, M.J.2
Strassburg, C.P.3
-
18
-
-
0034091316
-
Pulmonary hypertension
-
Krowka MJ. Pulmonary hypertension. Mayo Clin Proc 2000;75:625-630
-
(2000)
Mayo Clin Proc
, vol.75
, pp. 625-630
-
-
Krowka, M.J.1
-
19
-
-
0036283402
-
Arterial oxygenation associated with portopulmonary hypertension
-
Swanson KL, Krowka MJ. Arterial oxygenation associated with portopulmonary hypertension. Chest 2002;121:1869-1875
-
(2002)
Chest
, vol.121
, pp. 1869-1875
-
-
Swanson, K.L.1
Krowka, M.J.2
-
20
-
-
20044372736
-
AASLD practice guidelines: Evaluation of patients for liver transplantation
-
Murray KF, Carithers RL. AASLD practice guidelines: evaluation of patients for liver transplantation. Hepatology 2005;47:1407-1432
-
(2005)
Hepatology
, vol.47
, pp. 1407-1432
-
-
Murray, K.F.1
Carithers, R.L.2
-
21
-
-
33845498354
-
Portopulmonary hypertension: Results from a 10-year screening algorithm
-
Krowka MJ, Swanson KL, Frantz RP, McGoon MD, Wiesner RH. Portopulmonary hypertension: results from a 10-year screening algorithm. Hepatology 2006;44:1502-1510
-
(2006)
Hepatology
, vol.44
, pp. 1502-1510
-
-
Krowka, M.J.1
Swanson, K.L.2
Frantz, R.P.3
McGoon, M.D.4
Wiesner, R.H.5
-
23
-
-
77649152602
-
-
Ricci GL, Melgosa MT, Burgos F, Valera JL, Pizarro S, Roca J, et al. Assessment of acute pulmonary vascular reactivity in portopulmonary hypertension.
-
Assessment of Acute Pulmonary Vascular Reactivity in Portopulmonary Hypertension
-
-
Ricci, G.L.1
Melgosa, M.T.2
Burgos, F.3
Valera, J.L.4
Pizarro, S.5
Roca, J.6
-
24
-
-
0033915234
-
Pulmonary hemodynamics and perioperative cardiopulmonary mortality in patients with portopulmonary hypertension undergoing liver transplantation
-
Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443-450
-
(2000)
Liver Transpl
, vol.6
, pp. 443-450
-
-
Krowka, M.J.1
Plevak, D.J.2
Findlay, J.Y.3
Rosen, C.B.4
Wiesner, R.H.5
Krom, R.A.6
-
25
-
-
0030774349
-
Severe pulmonary hypertension in liver transplant candidates
-
Ramsay MA, Simpson BR, Nguyen AT, Ramsay KJ, East C, Klintmalm GB. Severe pulmonary hypertension in liver transplant candidates. Liver Transpl Surg 1997;3:494-500.
-
(1997)
Liver Transpl Surg
, vol.3
, pp. 494-500
-
-
Ramsay, M.A.1
Simpson, B.R.2
Nguyen, A.T.3
Ramsay, K.J.4
East, C.5
Klintmalm, G.B.6
-
26
-
-
10744230826
-
Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database
-
Krowka MJ, Mandell MS, Ramsay MA, Kawut SM, Fallon MB, Manzarbeitia C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl 2004;10:174-182
-
(2004)
Liver Transpl
, vol.10
, pp. 174-182
-
-
Krowka, M.J.1
Mandell, M.S.2
Ramsay, M.A.3
Kawut, S.M.4
Fallon, M.B.5
Manzarbeitia, C.6
-
27
-
-
0036245134
-
Outcome of liver transplantation for patients with pulmonary hypertension
-
Starkel P, Vera A, Gunson B, Mutimer D. Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 2002;8:383-388
-
(2002)
Liver Transpl
, vol.8
, pp. 383-388
-
-
Starkel, P.1
Vera, A.2
Gunson, B.3
Mutimer, D.4
-
29
-
-
2342453333
-
Portopulmonary hypertension and hepatopulmonary syndrome
-
Hoeper MM, Krowka MJ, Strassburg CP. Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363:1461-1468
-
(2004)
Lancet
, vol.363
, pp. 1461-1468
-
-
Hoeper, M.M.1
Krowka, M.J.2
Strassburg, C.P.3
-
30
-
-
0031719459
-
The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension
-
Rich S, Seidlitz M, Dodin E, Osimani D, Judd D, Genthner D, et al. The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998;114:787-792
-
(1998)
Chest
, vol.114
, pp. 787-792
-
-
Rich, S.1
Seidlitz, M.2
Dodin, E.3
Osimani, D.4
Judd, D.5
Genthner, D.6
-
32
-
-
0028944179
-
Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis
-
Ota K, Shijo H, Kokawa H, Kubara K, Kim T, Akiyoshi N, et al. Effects of nifedipine on hepatic venous pressure gradient and portal vein blood flow in patients with cirrhosis. J Gastroenterol Hepatol 1995;10:198-204.
-
(1995)
J Gastroenterol Hepatol
, vol.10
, pp. 198-204
-
-
Ota, K.1
Shijo, H.2
Kokawa, H.3
Kubara, K.4
Kim, T.5
Akiyoshi, N.6
-
33
-
-
0023688192
-
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
-
Navasa M, Bosch J, Reichen J, Bru C, Mastai R, Zysset T, et al. Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension. Hepatology 1988;8:850-854
-
(1988)
Hepatology
, vol.8
, pp. 850-854
-
-
Navasa, M.1
Bosch, J.2
Reichen, J.3
Bru, C.4
Mastai, R.5
Zysset, T.6
-
34
-
-
0032870286
-
Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension
-
Krowka MJ, Frantz RP, McGoon MD, Severson C, Plevak DJ, Weisner RH. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 1999;30:641-648
-
(1999)
Hepatology
, vol.30
, pp. 641-648
-
-
Krowka, M.J.1
Frantz, R.P.2
McGoon, M.D.3
Severson, C.4
Plevak, D.J.5
Weisner, R.H.6
-
35
-
-
34250680970
-
Long-term follow- up of portopulmonary hypertension: Effect of treatment with epoprostenol
-
Fix OK, Bass NM, De Marco T, Merriman RB. Long-term follow- up of portopulmonary hypertension: effect of treatment with epoprostenol. Liver Transpl 2007;13:875-885
-
(2007)
Liver Transpl
, vol.13
, pp. 875-885
-
-
Fix, O.K.1
Bass, N.M.2
De Marco, T.3
Merriman, R.B.4
-
36
-
-
0034893886
-
Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol
-
Tan HP, Markowitz JS, Montgomery RA, Merritt WT, Klein AS, Thuluvath PL, et al. Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol. Liver Transpl 2001;7:745-749
-
(2001)
Liver Transpl
, vol.7
, pp. 745-749
-
-
Tan, H.P.1
Markowitz, J.S.2
Montgomery, R.A.3
Merritt, W.T.4
Klein, A.S.5
Thuluvath, P.L.6
-
37
-
-
0031041342
-
Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension
-
Kuo PC, Johnson LB, Plotkin JS, Howell CD, Bartlett ST, Rubin LJ. Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 1997;63:604-606
-
(1997)
Transplantation
, vol.63
, pp. 604-606
-
-
Kuo, P.C.1
Johnson, L.B.2
Plotkin, J.S.3
Howell, C.D.4
Bartlett, S.T.5
Rubin, L.J.6
-
38
-
-
0032833889
-
Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension
-
Findlay JY, Plevak DJ, Krowka MJ, Sack EM, Porayko MK. Progressive splenomegaly after epoprostenol therapy in portopulmonary hypertension. Liver Transpl Surg 1999;5:362-365
-
(1999)
Liver Transpl Surg
, vol.5
, pp. 362-365
-
-
Findlay, J.Y.1
Plevak, D.J.2
Krowka, M.J.3
Sack, E.M.4
Porayko, M.K.5
-
40
-
-
6444229321
-
Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension
-
Minder S, Fischler M, Muellhaupt B, Zalunardo MP, Jenni R, Clavien PA, et al. Intravenous iloprost bridging to orthotopic liver transplantation in portopulmonary hypertension. Eur Respir J 2004;24:703-707
-
(2004)
Eur Respir J
, vol.24
, pp. 703-707
-
-
Minder, S.1
Fischler, M.2
Muellhaupt, B.3
Zalunardo, M.P.4
Jenni, R.5
Clavien, P.A.6
-
41
-
-
24744458364
-
Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan
-
Halank M, Kolditz M, Miehlke S, Schiemanck S, Schmeisser A, Hoeffken G. Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan. Wien Med Wochenschr 2005;155:376-380
-
(2005)
Wien Med Wochenschr
, vol.155
, pp. 376-380
-
-
Halank, M.1
Kolditz, M.2
Miehlke, S.3
Schiemanck, S.4
Schmeisser, A.5
Hoeffken, G.6
-
42
-
-
38849092105
-
Experience with inhaled iloprost and bosentan in portopulmonary hypertension
-
Hoeper MM, Seyfarth HJ, Hoeffken G, Wirtz H, Spiekerkoetter E, Pletz MW, et al. Experience with inhaled iloprost and bosentan in portopulmonary hypertension. Eur Respir J 2007;30:1096-1102
-
(2007)
Eur Respir J
, vol.30
, pp. 1096-1102
-
-
Hoeper, M.M.1
Seyfarth, H.J.2
Hoeffken, G.3
Wirtz, H.4
Spiekerkoetter, E.5
Pletz, M.W.6
-
43
-
-
11144259340
-
Use of a mixed receptor antagonist in portopulmonary hypertension: A safe and effective therapy?
-
Kuntzen C, Guelberg V, Gerbes AL. Use of a mixed receptor antagonist in portopulmonary hypertension: a safe and effective therapy? Gastroenterology 2005;128:164-168
-
(2005)
Gastroenterology
, vol.128
, pp. 164-168
-
-
Kuntzen, C.1
Guelberg, V.2
Gerbes, A.L.3
-
44
-
-
9144272742
-
Endothelin-receptor antagonist treatment of portopulmonary hypertension
-
Hinterhuber L, Graziadei IW, Kahler CM, Jaschke W, Vogel W. Endothelin-receptor antagonist treatment of portopulmonary hypertension. Clin Gastroenterol Hepatol 2004;2:1039-1042
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 1039-1042
-
-
Hinterhuber, L.1
Graziadei, I.W.2
Kahler, C.M.3
Jaschke, W.4
Vogel, W.5
-
45
-
-
14744304820
-
Bosentan therapy for portopulmonary hypertension
-
Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, et al. Bosentan therapy for portopulmonary hypertension. Eur Respir J 2005;25:502-508
-
(2005)
Eur Respir J
, vol.25
, pp. 502-508
-
-
Hoeper, M.M.1
Halank, M.2
Marx, C.3
Hoeffken, G.4
Seyfarth, H.J.5
Schauer, J.6
-
46
-
-
2942639967
-
Use of oral endothelin receptor antagonist bosentan in the treatment of portopulmonary hypertension
-
Halank M, Miehke S, Hoeffken G, Schmeisser A, Schulze M, Strasser RH. Use of oral endothelin receptor antagonist bosentan in the treatment of portopulmonary hypertension. Transplantation 2004;77:1775-1776
-
(2004)
Transplantation
, vol.77
, pp. 1775-1776
-
-
Halank, M.1
Miehke, S.2
Hoeffken, G.3
Schmeisser, A.4
Schulze, M.5
Strasser, R.H.6
-
47
-
-
41949105559
-
Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension
-
Idrees MM, Al-Hajjaj M, Khan J, Al-Hazmi M, Alanezi M, Saleemi S, et al. Saudi guidelines on diagnosis and treatment of pulmonary arterial hypertension. Ann Thorac Med 2008;3:1-57.
-
(2008)
Ann Thorac Med
, vol.3
, pp. 51-57
-
-
Idrees, M.M.1
Al-Hajjaj, M.2
Khan, J.3
Al-Hazmi, M.4
Alanezi, M.5
Saleemi, S.6
-
48
-
-
15544369773
-
Novel use of sildenafil in the treatment of portopulmonary hypertension
-
DOI 10.1016/j.healun.2004.01.017
-
Chua R, Keogh A, Miyashita M. Novel use of sildenafil in the treatment of portopulmonary hypertension. J Heart Lung Transplant 2005;24:498-500. (Pubitemid 40403811)
-
(2005)
Journal of Heart and Lung Transplantation
, vol.24
, Issue.4
, pp. 498-500
-
-
Chua, R.1
Keogh, A.2
Miyashita, M.3
-
49
-
-
3242762283
-
Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation
-
Makisalo H, Koivusalo A, Vakkuri A, Hockerstedt K. Sildenafil for portopulmonary hypertension in a patient undergoing liver transplantation. Liver Transpl 2004;10:945-950
-
(2004)
Liver Transpl
, vol.10
, pp. 945-950
-
-
Makisalo, H.1
Koivusalo, A.2
Vakkuri, A.3
Hockerstedt, K.4
-
50
-
-
33750098824
-
Sildenafil treatment for portopulmonary hypertension
-
Reichenberger F, Voswinckel R, Steveling E, Enke B, Kreckel A, Olschewski H, et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J 2006;28:563-567
-
(2006)
Eur Respir J
, vol.28
, pp. 563-567
-
-
Reichenberger, F.1
Voswinckel, R.2
Steveling, E.3
Enke, B.4
Kreckel, A.5
Olschewski, H.6
-
51
-
-
70350283761
-
Combination therapy: The Future of medical management for PAH
-
Available from
-
Murali S., Combination therapy: The Future of medical management for PAH. Medscape Cardiol 2005;9:2. Available from: http://cme.medscape.com/viewarticle/ 513613.
-
(2005)
Medscape Cardiol
, vol.9
, pp. 2
-
-
Murali, S.1
-
52
-
-
41149138871
-
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension
-
Austin MJ, McDougall NI, Wendon JA, Sizer E, Knisely AS, Rela M, et al. Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension. Liver Transpl 2008;14:287-291
-
(2008)
Liver Transpl
, vol.14
, pp. 287-291
-
-
Austin, M.J.1
McDougall, N.I.2
Wendon, J.A.3
Sizer, E.4
Knisely, A.S.5
Rela, M.6
-
53
-
-
0033915234
-
Pulmonary hemodynamics and perioperative cardiopulmonary related mortality in patients with portopulmonary hypertension undergoing liver transplantation
-
Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Weisner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000;6:443-450
-
(2000)
Liver Transpl
, vol.6
, pp. 443-450
-
-
Krowka, M.J.1
Plevak, D.J.2
Findlay, J.Y.3
Rosen, C.B.4
Weisner, R.H.5
Krom, R.A.6
|